Foundayo vs Wegovy: Which GLP-1 Is Right for You?
Foundayo and Wegovy are both GLP-1 medications approved for weight loss, but they work differently, cost differently, and fit different lifestyles. Foundayo (orforglipron) is Eli Lilly's new daily pill — no food restrictions, no injections. Wegovy (semaglutide) is available as a weekly injection or daily pill (with fasting requirements). Here's how they compare on everything that matters.
Ready to act? Oral GLP-1 options from $99/mo
MEDVi offers GLP-1 tablets and injectables — a licensed provider helps you choose.
Weight Loss: How Do They Compare?
Wegovy injectable wins on raw efficacy. In the STEP 1 trial, Wegovy (semaglutide 2.4mg injection) showed approximately 15% body weight loss (ITT/treatment regimen) to 17% (completers) over 68 weeks. That's the gold standard for single-agent GLP-1 weight loss.
Foundayo is competitive but not quite as powerful. In ATTAIN-1, the highest approved dose (17.2mg) showed 11.2% weight loss (ITT/treatment regimen) to 12.4% (completers) over 72 weeks. Note: Side effect data from ATTAIN-1 comes from the 36mg trial dose (higher than approved doses), so real-world side effect rates at approved doses may be lower.
Wegovy pill vs Foundayo is closer. Oral semaglutide shows somewhat lower efficacy than injectable Wegovy (the oral bioavailability is only ~1%). When comparing pills to pills, Foundayo and oral Wegovy are in a similar range.
Bottom line: If maximum weight loss is your top priority and you don't mind injections, Wegovy injectable is the stronger drug. If you want a pill, Foundayo and oral Wegovy deliver similar results, but Foundayo wins on convenience (no fasting).
Cost Comparison
Cost is where Foundayo shines — see our full Foundayo cost and pricing guide for details:
- Foundayo self-pay: $149/month (starting dose) to $349/month (highest dose) via LillyDirect
- Wegovy injectable: ~$1,349/month list price
- Wegovy pill: $149/month for 1.5mg and 4mg doses. Higher dose pricing not yet publicly set at self-pay level.
With manufacturer savings cards, both can drop to $25/month for commercially insured patients. But for the ~16 million Americans without GLP-1 coverage, the self-pay price is what matters.
Key insight: At lower/middle doses, Foundayo is significantly cheaper. At the highest dose, Wegovy pill ($299) actually undercuts Foundayo ($349). But Foundayo starts at just $149, making it the most affordable way to get started on a GLP-1.
Convenience & Lifestyle
Foundayo wins decisively on convenience:
- Take any time of day — morning, noon, or night
- With or without food and water — no restrictions
- No injection, no needles, no cold storage
- Easy to travel with — no sharps container needed
Wegovy pill requires strict fasting: You must take it on an empty stomach with a small sip of water, then wait 30 minutes before eating, drinking, or taking other medications. For many people, this is a significant daily inconvenience.
Wegovy injection: Once weekly is convenient scheduling-wise, but requires injection, cold storage, and sharps disposal. Some people develop injection fatigue over months or years.
Side Effects Comparison
Both medications cause GI side effects — that's the nature of GLP-1s. But the rates differ (see our Foundayo side effects week-by-week guide for what to expect):
Foundayo (from ATTAIN-1 at 36mg highest trial dose):
- Nausea: 33.7%
- Constipation: 25.4%
- Diarrhea: 23.1%
- Vomiting: 24.0%
- Dyspepsia: 14.1%
- Hair loss: ~4-5%
- Discontinuation due to AEs: 10.3%
Wegovy injectable (from STEP trials):
- Nausea: ~44%
- Diarrhea: ~30%
- Vomiting: ~24%
- Constipation: ~24%
- Injection site reactions: ~6%
Foundayo has somewhat lower GI side effect rates than Wegovy injectable. As a non-peptide small molecule GLP-1 receptor agonist, orforglipron may produce a different side effect profile compared to semaglutide's peptide-based full agonism. However, direct comparison is difficult because the trials had different designs and patient populations.
Who Should Choose Which?
Choose Foundayo if:
- You want a pill with no food/water restrictions
- You're price-sensitive (starting at $149/mo self-pay)
- You've had bad GI side effects on other GLP-1s
- You're starting GLP-1 treatment for the first time
- You're switching from an injectable and want oral convenience
Choose Wegovy if:
- Maximum weight loss is your top priority
- You don't mind weekly injections (for the injectable version)
- You're already on semaglutide and it works for you
- Your insurance covers Wegovy but not Foundayo
- You prefer the longer safety track record (5+ years of data)
Already on Zepbound and considering a switch to an oral option? Foundayo also works well for weight maintenance after Zepbound.
Compare Your Personalized Switch Plan
Frequently Asked Questions
Sources
- ATTAIN-1 Phase 3 Trial (NCT05869903) — orforglipron weight loss data
- STEP Clinical Trial Program — semaglutide (Wegovy) weight loss data
- Foundayo (orforglipron) FDA Prescribing Information, Eli Lilly
- Wegovy (semaglutide) FDA Prescribing Information, Novo Nordisk
- Eli Lilly pricing announcement, April 1, 2026
- Business Insider: Foundayo vs Zepbound, Wegovy, Rybelsus comparison, April 2026
Don't miss price changes
GLP-1 prices are changing — stay ahead
Foundayo prices may increase — get alerts before they do. Track price drops, shortages, and new switching guidance without checking back manually.
- Price increase warnings before they hit
- Savings card and coupon alerts
- New switching guidance and availability updates
No spam. Unsubscribe anytime. We never share your email.
Compare GLP-1 Providers
Get a prescription in as little as 24 hours — no in-person visit required.
GLP-1 weight loss program — take a 60-second quiz to see if you qualify. Compounded semaglutide and tirzepatide from $99/month with provider support.
Starts at $99/mo — one of the most affordable GLP-1 programs
MedSwitcher may earn a commission from some providers. Full disclosure. This does not affect our recommendations.
Recommended Products
Supplies and tools commonly used by GLP-1 patients during their treatment journey.
As an Amazon Associate, MedSwitcher earns from qualifying purchases. Product links do not affect our clinical recommendations.